Results 21 to 30 of about 19,040 (169)

Heparin-induced thrombocytopenia among patients of a comprehensive cancer center

SAGE Open Medical Case Reports, 2014
Most clinical studies of heparin-induced thrombocytopenia have not included cancer patients who have high risk of thromboembolism, frequent exposure to heparin, and many potential causes of thrombocytopenia other than heparin-induced thrombocytopenia. To
Weixin Wu, Kelly Merriman, Amr Nabaah, Nikhil Seval, Vahid Afshar-Kharghan, Sai-Ching J Yeung   +5 more
doaj   +1 more source

Spontaneous Heparin-Induced Thrombocytopenia Presenting as Concomitant Bilateral Cerebrovascular Infarction and Acute Coronary Syndrome

Cardiovascular Innovations and Applications, 2023
Background: Spontaneous heparin-induced thrombocytopenia is a pro-thrombotic syndrome in which anti-heparin antibodies develop without heparin exposure. Case presentation: A 78-year-old man who underwent a successful lumbar laminectomy presented to the
Jong Kun Park, Ilan Vavilin, Jacob Zaemes, Araba Ofosu-Somuah, Raghav Gattani, Camila Sahebi, Alexander G. Truesdell   +6 more
doaj   +1 more source

Heparin-Induced Thrombocytopenia

Annals of Pharmacotherapy, 1998
OBJECTIVE To highlight the importance of heparin-induced thrombocytopenia (HIT), a potentially fatal adverse effect of heparin therapy. CASE SUMMARY: There are two types of HIT with a distinct etiology.
A K, Gupta, M J, Kovacs, D N, Sauder
openaire   +4 more sources

Delayed-onset heparin-induced thrombocytopenia presenting with multiple arteriovenous thromboses: case report

Journal of Medical Case Reports, 2007
Background Delayed-onset heparin-induced thrombocytopenia with thrombosis, albeit rare, is a severe side effect of heparin exposure. It can occur within one month after coronary artery bypass grafting (CABG) with manifestation of different thrombotic ...
Omran Abbas, Karimi Abbasali, Ahmadi Hossein, Yazdanifard Parin   +3 more
doaj   +1 more source

Spontaneous heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages and pulmonary embolism after total knee arthroplasty

Arthroplasty Today, 2015
Heparin-induced thrombocytopenia syndrome is an acquired potentially life-threatening prothrombotic disorder caused by antibodies that recognize complexes of platelet factor 4 bound to heparin or heparin-like molecules. It typically occurs after exposure
Amro Elshoury, MBChB, Maha Khedr, MBChB, Mostafa M. Abousayed, MD, Syed Mehdi, MD   +3 more
doaj   +1 more source

Injection Site Erythema in a Patient on Therapeutic Anticoagulation with Low Molecular Weight Heparin after Mechanical Aortic Valve Replacement: A Rare Presentation of Heparin- and Protamine-Induced Thrombocytopenia

Case Reports in Immunology, 2020
Previous exposition to heparin and protamine in patients undergoing cardiopulmonary bypass and postoperative therapeutic anticoagulation with LMWH may lead to the development of heparin-induced thrombocytopenia (HIT) and/or protamine-induced ...
Caroline Holaubek, Paul Simon, Sabine Eichinger-Hasenauer, Franz Gremmel, Barbara Steinlechner   +4 more
doaj   +1 more source

“Spontaneous” Heparin-Induced Thrombocytopenia and Thrombosis After Total Knee Arthroplasty: A Report of 2 Cases

Arthroplasty Today, 2021
“Spontaneous” heparin-induced thrombocytopenia is a rare and virulent form of heparin-induced thrombocytopenia that occurs in the absence of exposure to any drug of the heparin class of anticoagulants.
Olga M. Olevsky, MD, Michael H. Rosove, MD   +1 more
doaj   +1 more source

Acute renal failure due to bilateral renal vein thromboses: A rare complication of heparin-induced thrombocytopenia

Annals of Cardiac Anaesthesia, 2019
Heparin-induced thrombocytopenia type II is a rare but devastating complication of heparin exposure. We review a case of a 66-year-old female who underwent aortic valve surgery requiring venoarterial extracorporeal membranous oxygenation (ECMO) support ...
Allan M Klompas, Robert C Albright, Simon Maltais, Onur Demirci   +3 more
doaj   +1 more source

Successful Use of Intravenous Immunoglobulin G to Treat Refractory Heparin-Induced Thrombocytopenia With Thrombosis Complicating Peripheral Blood Stem Cell Harvest

Journal of Investigative Medicine High Impact Case Reports, 2018
Heparin-induced thrombocytopenia is a well-known, life-threatening complication that occurs in 5% of patients exposed to heparin. It causes thrombocytopenia in roughly 85% to 90% of affected individuals, with expected recovery in approximately 4 to 10 ...
Devon S. McKenzie MD, Josephine Anuforo MD, Jennah Morgan MD, Elvira Neculiseanu MD   +3 more
doaj   +1 more source

Deterioration of vaccine‐induced immune thrombotic thrombocytopenia treated by heparin and platelet transfusion: Insight from functional cytometry and serotonin release assay

Research and Practice in Thrombosis and Haemostasis, 2021
We report a case of a 62‐year‐old man who developed cerebral venous sinus thrombosis with subarachnoid hemorrhage and concomitant thrombocytopenia, which occurred 13 days after ChAdOx1 nCov‐19 injection.
Alice Bérezné, David Bougon, Florence Blanc‐Jouvan, Nicolas Gendron, Cecile Janssen, Michel Muller, Sébastien Bertil, Florence Desvard, Isabelle Presot, Benjamin Terrier, Richard Chocron, Olivier Sanchez, Dominique Helley, David M. Smadja   +13 more
doaj   +1 more source